Letter in Reply: indirect comparison of quality-of-life scores between patients with advanced breast cancer receiving palbociclib and abemaciclib in combination with fulvestrant

Detalles Bibliográficos
Autores principales: Law, Ernest H, Cameron, Chris
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Becaris Publishing Ltd 2023
Materias:
Letter in Reply
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402903/
https://www.ncbi.nlm.nih.gov/pubmed/37114409
http://dx.doi.org/10.57264/cer-2023-0009

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10402903/
https://www.ncbi.nlm.nih.gov/pubmed/37114409
http://dx.doi.org/10.57264/cer-2023-0009

Ejemplares similares